A semi-synthetic oligosaccharide conjugate vaccine candidate confers protection against Streptococcus pneumoniae serotype 3 infection

The identification of immunogenic glycotopes that render glycoconjugate vaccines protective is key to improving vaccine efficacy. Synthetic oligosaccharides are an attractive alternative to the heterogeneous preparations of purified polysaccharides that most marketed glycoconjugate vaccines are base...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cell Chem Biol
Glavni autori: Parameswarappa, Sharavathi Guddehalli, Reppe, Katrin, Geissner, Andreas, Ménová, Petra, Govindan, Subramanian, Calow, Adam D. J., Wahlbrink, Annette, Weishaupt, Markus W., Monnanda, Bopanna Ponnappa, Bell, Roland Lawrence, Pirofski, Liise-anne, Suttorp, Norbert, Sander, Leif Erik, Witzenrath, Martin, Pereira, Claney Lebev, Anish, Chakkumkal, Seeberger, Peter H.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5234679/
https://ncbi.nlm.nih.gov/pubmed/27818299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chembiol.2016.09.016
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items